Prosecution Insights
Last updated: August 18, 2026

Examiner: PATEL, OM

Tech Center 3700 • Art Units: 3791

This examiner grants 58% of resolved cases

Performance Statistics

58.3%
Allow Rate
-11.7% vs TC avg
146
Total Applications
+54.4%
Interview Lift
1325
Avg Prosecution Days
Based on 115 resolved cases, 2023–2026

Rejection Statute Breakdown

10.3%
§101 Eligibility
13.4%
§102 Novelty
54.4%
§103 Obviousness
21.4%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18184794 GUIDEWIRE WITH PORTIONS OF REDUCED STIFFNESS Non-Final OA Boston Scientific Medical Device Limited
18501255 VITAL SIGN OBTAINING DEVICE, NON-TRANSITORY COMPUTER READABLE STORAGE MEDIUM, AND VITAL SIGN OBTAINING SYSTEM Final Rejection Nihon Kohden Corporation
18733310 Blood Draw Syringe With Hemolysis Protection Non-Final OA Becton, Dickinson and Company
18243759 Introducer Housing for Blood Draw Device Final Rejection Becton, Dickinson and Company
18215610 PORTED CATHETERS CONFIGURED TO FACILITATE INSERTION OF BLOOD DRAW DEVICE Final Rejection Becton, Dickinson and Company
18033967 BLOOD COLLECTION DEVICES, SYSTEMS, AND METHODS Final Rejection Becton, Dickinson and Company
18127934 Device for Manually Locking an Inserted Line Draw Device to Prevent Premature Retraction Final Rejection Becton, Dickinson and Company
17851621 Instrument Delivery Device With Different Guidewire and Tubing Advancement Ratios Non-Final OA Becton, Dickinson and Company
17575809 Blood Draw Assembly and Related Devices and Methods Final Rejection Becton, Dickinson and Company
18612072 DECISION SUPPORT AND TREATMENT ADMINISTRATION SYSTEMS Final Rejection Dexcom, Inc.
17559194 BOLUS ADVISOR WITH CORRECTION BOLUSES BASED ON RISK, CARB-FREE BOLUS RECOMMENDER, AND MEAL ACKNOWLEDGEMENT Final Rejection Dexcom, Inc.
18562836 BATTERY SHELL INTEGRATED ANALYTE DETECTION DEVICE Final Rejection MEDTRUM TECHNOLOGIES INC.
17493281 MICROFABRICATED CORE WIRE FOR AN INTRAVASCULAR DEVICE Non-Final OA SCIENTIA VASCULAR, LLC

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month